Literature DB >> 11414599

Update: influenza activity--United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine.

.   

Abstract

The 2000-01 influenza season was mild in the United States and was the first season since 1995-96 that was not predominated by A (H3N2) viruses. Influenza A (H1N1) viruses predominated in the United States. In some regions, however, influenza B viruses were reported more frequently than influenza A viruses. Worldwide, influenza A (H1N1) and B viruses also predominated. This report summarizes U.S.* and worldwide influenza activity during the 2000-01 influenza season and describes the composition of the 2001-02 influenza vaccine.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11414599

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  10 in total

1.  Seasonal influenza in the United States, France, and Australia: transmission and prospects for control.

Authors:  G Chowell; M A Miller; C Viboud
Journal:  Epidemiol Infect       Date:  2007-07-18       Impact factor: 2.451

2.  Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan.

Authors:  Shin-Ru Shih; Guang-Wu Chen; Ching-Chun Yang; Weng-Zhi Yang; Ding-Ping Liu; Jih-Hui Lin; Shu-Chun Chiu; Haur-Young Chen; Kuo-Chien Tsao; Chung-Guei Huang; Ya-Ling Huang; Chee-Keng Mok; Chi-Jene Chen; Tzou-Yien Lin; Jen-Ren Wang; Chuan-Liang Kao; Kwei-Hsian Lin; Li-Kuang Chen; Hock-Liew Eng; Yung-Ching Liu; Po-Yen Chen; Jen-Shiou Lin; Jen-Hsien Wang; Cheng-Wen Lin; Yu-Jiun Chan; Jang-Jih Lu; Chao A Hsiung; Pei-Jer Chen; Ih-Jen Su
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 3.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

4.  Influenza surveillance in Korea: establishment and first results of an epidemiological and virological surveillance scheme.

Authors:  J-S Lee; K-C Shin; B-K Na; J-Y Lee; C Kang; J-H Kim; O Park; E-K Jeong; J-K Lee; J-W Kwon; S-C Park; W-J Kim
Journal:  Epidemiol Infect       Date:  2007-02-12       Impact factor: 2.451

5.  Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.

Authors:  Leah J McGrath; Abhijit V Kshirsagar; Stephen R Cole; Lily Wang; David J Weber; Til Stürmer; M Alan Brookhart
Journal:  Arch Intern Med       Date:  2012-04-09

6.  Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.

Authors:  Bruce D Forrest; Michael W Pride; Andrew J Dunning; Maria Rosario Z Capeding; Tawee Chotpitayasunondh; John S Tam; Ruth Rappaport; John H Eldridge; William C Gruber
Journal:  Clin Vaccine Immunol       Date:  2008-04-30

7.  Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.

Authors:  Eric A Weaver; Adam M Rubrum; Richard J Webby; Michael A Barry
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

8.  Influenza A virus PB1-F2 gene in recent Taiwanese isolates.

Authors:  Guang-Wu Chen; Ching-Chun Yang; Kuo-Chien Tsao; Chung-Guei Huang; Li-Ang Lee; Wen-Zhi Yang; Ya-Ling Huang; Tzou-Yien Lin; Shin-Ru Shih
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

9.  Molecular epidemiology of influenza A/H3N2 viruses circulating in Mexico from 2003 to 2012.

Authors:  Marina Escalera-Zamudio; Martha I Nelson; Ana Georgina Cobián Güemes; Irma López-Martínez; Natividad Cruz-Ortiz; Miguel Iguala-Vidales; Elvia Rodríguez García; Gisela Barrera-Badillo; Jose Alberto Díaz-Quiñonez; Susana López; Carlos F Arias; Pavel Isa
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

10.  The burden of community-acquired pneumonia in seniors: results of a population-based study.

Authors:  Michael L Jackson; Kathleen M Neuzil; William W Thompson; David K Shay; Onchee Yu; Christi A Hanson; Lisa A Jackson
Journal:  Clin Infect Dis       Date:  2004-11-08       Impact factor: 9.079
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.